Preclinical isolated organ perfusion system market
Preclinical Isolated Organ Perfusion System Market, by Type (Isolated Heart Perfusion Systems, Isolated Abdominal Organ Perfusion Systems, Isolated Lung Perfusion Systems and Others), by End User (Industrial Laboratories and CROs and Academic and Government Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
- Dec 2020
- CMI4351
- 198 Pages
- Excel & Pdf
- Medical Devices
Isolated organ perfusion involves maintaining an organ in viable status, either by single pass or recirculation with the medium. Isolated organ perfusion has been documented in distribution studies involving several organs including lung, kidney and brain. These isolated organ perfusion techniques allow higher concentrations of chemotherapy to be delivered to the targeted organ while ensuring the vitality of other organs. Increasing organ transplantation across the globe is expected to boost the market growth. For instance, according to an article titled Consortium on Organ Preservation in Europe (COPE) published by the CORDIS European Commission in December 2018, the prevalence of end-stage chronic kidney disease is around 4.1-8% in the over 18-age group in the U.K.
The global preclinical isolated organ perfusion system market is estimated to be valued at US$ 442.8 million in 2020 and is expected to exhibit a CAGR of 4.2% during the forecast period (2020-2027).
Figure 1. Global Preclinical Isolated Organ Perfusion System Market Share (%), by Region, 2020
Rising cases of cardiovascular diseases worldwide are expected to propel growth of the global preclinical isolated organ perfusion system market.
Rising incidence of cardiovascular worldwide is expected to drive the market growth during the forecast period. For instance, according to an article published by the World Health Organization, 2018, 15 million people suffer stroke worldwide each year. Out of these, 5 million die and another 5 million are permanently disabled.
Preclinical Isolated Organ Perfusion System Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2019 | Market Size in 2020: | US$ 442.8 Mn |
| Historical Data for: | 2016 to 2019 | Forecast Period: | 2020 to 2027 |
| Forecast Period 2020 to 2027 CAGR: | 4.2% | 2027 Value Projection: | US$ 589.1 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
World Precision Instruments Inc., Radnoti LLC, MDE GmbH, Harvard Bioscience Inc., emka TECHNOLOGIES S.A.S., Danish Myo Technology AS, ADInstruments Pty Ltd. and Experimetria Ltd. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Figure 2. Global Preclinical Isolated Organ Perfusion System Market Share (%), by Type, 2020
The increasing incidence of cardiovascular diseases in North America is expected to drive the market growth.
North America is expected to hold dominant position in the global preclinical isolated organ perfusion system market owing to increasing prevalence of cardiovascular diseases in the region. For instance, according to an article published by the Centers for Disease Control and Prevention Report, in 2020, around 18.2 million adults over 30 years of age suffered from coronary artery disease in the U.S.
Global Preclinical Isolated Organ Perfusion System Market – Impact of Coronavirus (COVID-19) Pandemic
The coronavirus (COVID-19) pandemic and resulting lockdowns in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare is one such sector which has been impacted significantly by the COVID-19 pandemic.
Lockdowns in various countries have placed an economic burden on the healthcare sector. Moreover, the coronavirus pandemic has hampered the development, production, and supply of drugs and other healthcare products, and affected growth of healthcare businesses of various companies across the globe.
As a result, the impact of the COVID-19 pandemic is expected to limit growth of the global preclinical isolated organ perfusion system market during the forecast period.
Key Players
Major players operating in the global preclinical isolated organ perfusion system market are World Precision Instruments Inc., Radnoti LLC, MDE GmbH, Harvard Bioscience Inc., emka TECHNOLOGIES S.A.S., Danish Myo Technology AS, ADInstruments Pty Ltd. and Experimetria Ltd. among others.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- Reimbursement Scenario
- Epidemiology
- Pest Analysis
- Regulatory Scenario
- New Product Launches
- Collaborations and Agreements
- Market Trends
- Market Dynamics
- Global Preclinical Isolated Organ Perfusion System Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Market Scenario
- Impact of COVID-19 Market on the Preclinical Isolated Organ Perfusion System Products
- Global Preclinical Isolated Organ Perfusion System Market, By Type, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Isolated Heart Perfusion Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Isolated Abdominal Organ Perfusion Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Isolated Lung Perfusion Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Preclinical Isolated Organ Perfusion System Market, By End User, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Industrial Laboratories and CROs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Academic and Government Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Preclinical Isolated Organ Perfusion System Market, By Region, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2027
- North America
- Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- World Precision Instruments Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Radnoti LLC
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- MDE GmbH
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Harvard Bioscience Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- emka TECHNOLOGIES S.A.S.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Danish Myo Technology AS
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- ADInstruments Pty Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Experimetria Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- World Precision Instruments Inc.
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 38 market data tables and 33 figures on "Preclinical Isolated Organ Perfusion System Market” - Global forecast to 2027